Precision BioSciences CFO Naresh Tanna files initial beneficial ownership statement
DTIL•Initial Form 3 filing details holdings
- Precision BioSciences CFO Naresh Tanna disclosed 25,575 common shares held directly in an initial SEC Form 3 filing.
- The filing also reported restricted stock units covering 226,006 shares.
